共 66 条
- [1] Hunziker T., Kunzi U.P., Braunschweig S., Et al., Comprehensive hospital drug monitoring (CHDM): Adverse skin reactions, a 20-year survey, Allergy, 52, pp. 388-393, (1997)
- [2] Pichler W.J., Schnyder B., Zanni M., Et al., Role of T cells in drug allergies, Allergy, 53, pp. 225-232, (1998)
- [3] Hero M., Merk H.F., Lymphocyte activation in cutaneous drug reactions, J Invest Dermatol, 105, pp. 95-98, (1995)
- [4] Hari Y., Frutig K., Hurni M., Et al., T cell involvement in cutaneous drug eruptions, Clin Exp Allergy, 31, pp. 1398-1403, (2001)
- [5] Britschgi M., Steiner U., Schmid S., Et al., T cell involvement in drug-induced acute generalized exanthematous pustulosis, J Clin Invest, 107, pp. 1433-1441, (2001)
- [6] Zanni M.P., Mauri-Hellweg D., Brander C., Et al., Characterization of lidocaine-specific T cells, J Immunol, 158, pp. 1139-1148, (1997)
- [7] Schnyder B., Mauri-Hellweg D., Zanni M., Et al., Direct, MHC-dependent presentation of the drug sulfamethoxazole to human T cell clones, J Clin Invest, 100, pp. 136-141, (1997)
- [8] Zanni M.P., Von Greyerz S., Schnyder B., Et al., HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human αaβb T lymphocytes, J Clin Invest, 102, pp. 1591-1598, (1998)
- [9] Schnyder B., Frutig K., Mauri-Hellweg D., Et al., T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction, Clin Exp Allergy, 28, pp. 1412-1417, (1998)
- [10] Yawalkar N., Egli F., Hari Y., Et al., Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions, Clin Exp Allergy, 30, pp. 847-855, (2000)